Enzo Biochem, Inc.
ENZ was delisted on the 17th of April, 2025.
116 hedge funds and large institutions have $313M invested in Enzo Biochem, Inc. in 2017 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 41 increasing their positions, 32 reducing their positions, and 22 closing their positions.
28% more repeat investments, than reductions
Existing positions increased: 41 | Existing positions reduced: 32
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
3% less capital invested
Capital invested by funds: $322M → $313M (-$9.28M)
3% less funds holding
Funds holding: 120 → 116 (-4)
14% less first-time investments, than exits
New positions opened: 19 | Existing positions closed: 22
62% less call options, than puts
Call options by funds: $436K | Put options by funds: $1.16M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TCIM
TIAA CREF Investment Management
New York
|
+$2.24M |
| 2 |
CAM
ClariVest Asset Management
San Diego,
California
|
+$1.65M |
| 3 |
BlackRock
New York
|
+$1.6M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.55M |
| 5 |
MCM
Marathon Capital Management
Hunt Valley,
Maryland
|
+$1.52M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
-$1.97M |
| 2 |
Two Sigma Investments
New York
|
-$1.97M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
-$1.36M |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$1.13M |
| 5 |
AHB
Abner Herrman & Brock
Jersey City,
New Jersey
|
-$1.1M |
ENZ Hedge Fund Activity: Q3 2017 in Review
116 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Enzo Biochem, Inc. (ENZ) for Q3 2017, worth a combined $313M — down 2.9% from $322M a quarter earlier.
Sellers outnumbered buyers: 22 funds closed out of ENZ and 19 opened new positions — a net loss of 3 holders — while 32 trimmed existing stakes and 41 added.
The largest buyer was TIAA CREF Investment Management, adding an estimated $2.24M. The largest seller was First Light Asset Management, cutting an estimated $1.97M.
- 116 institutional investors held Enzo Biochem, Inc. (ENZ) as of Q3 2017, down from 120 in Q2 2017.
- Funds reported $313M of Enzo Biochem, Inc. stock for Q3 2017, down 2.9% quarter-over-quarter.
- 19 funds opened new Enzo Biochem, Inc. positions in Q3 2017 and 22 closed out, a net change of -3 holders.
- The largest Enzo Biochem, Inc. buyer in Q3 2017 was TIAA CREF Investment Management, an estimated $2.24M added.
- The largest Enzo Biochem, Inc. seller in Q3 2017 was First Light Asset Management, an estimated $1.97M sold.
Based on aggregated 13F filings for Q3 2017.